Compare Merck & Co., Inc. (MRK) vs Shopify Inc. (SHOP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs Shopify Inc. — how do they compare? Merck & Co., Inc. trades at $145.6 (market cap $351.28B), while Shopify Inc. trades at $170.85 (market cap $211.73B). The key difference: Merck & Co., Inc. is the larger of the two by market cap, and Merck & Co., Inc. pays a 2.39% dividend while Shopify Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Merck & Co., Inc. for 98 Days and Shopify Inc. for 78 Days on average.
| MRK | SHOP | |
|---|---|---|
Market Cap | $351.28B | $211.73B |
Volume | 7,969,665 | 7,146,651 |
Sector | Health | Technology |
52-Week High | $156.43 | $179.01 |
52-Week Low | $82.49 | $95.40 |
Typical Hold Time | 98 Days | 78 Days |
Enterprise Value | $398.04B | $206.96B |
Dividend Yield | 2.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Merck (MRK) trades at $142.40, down 0.28% on the day, with a bearish technical signal and key support at $140. The company reported strong earnings beats in recent quarters, with Q3 2026 EPS expected at $2.14. Revenue grew to $65.01B in 2025, and net income reached $18.25B, though the P/E ratio is elevated at 113.9. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline.
The outlook for MRK is mixed, with solid fundamentals and analyst optimism countered by high valuation and bearish technicals. The consensus price target of $158.78 suggests upside potential, but investors face risks from competitive pressures and integration challenges from recent M&A activity. Earnings growth and pipeline developments remain key catalysts.
Shopify trades at $164.54, down 0.84% on the day, with strong technical momentum indicated by bullish moving averages. The company demonstrates robust revenue growth, increasing from $5.6B in 2022 to $11.6B in 2025, though valuation ratios remain elevated with a P/E of 111.19. Recent developments include the launch of Canvas AI store builder and strategic moves in AI-powered commerce positioning.
Outlook remains positive with 67% analyst buy ratings and $168.63 consensus target, though high valuation and competitive pressures from Amazon present risks. Operating cash flow growth to $2.4B projected for 2026 supports continued investment in merchant solutions and AI capabilities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About Shopify Inc.
Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →
